Psychiatric NP Scope of Practice for Depression in Georgia

You spent years training to diagnose and treat depression. You know SSRIs, you know treatment-resistant cases, you know when to augment with a stimulant or manage co-occurring anxiety with a benzodiazepine. But when it comes to prescribing these medications via telehealth, the regulatory landscape feels like a minefield.

Can you start a new patient on Lexapro after a video visit? What about Adderall for ADHD comorbid with depression? Does your state even allow it? And what’s the deal with the DEA’s rules — are they still extending the COVID flexibilities, or are we back to requiring in-person visits?

Here’s the reality: As of early 2026, psychiatrists and PMHNPs can prescribe most depression medications via telehealth, including controlled substances, thanks to temporary DEA extensions that run through December 31, 2026. But the rules vary significantly by state, your provider type matters (MD vs NP), and the regulatory environment is in flux as the DEA finalizes permanent telehealth prescribing rules.

This guide cuts through the confusion. We’ll cover the current federal DEA rules, state-by-state telehealth prescribing laws for the six biggest markets (California, Texas, Florida, New York, Pennsylvania, Illinois), scope of practice differences between psychiatrists and PMHNPs, and what all of this means for your ability to treat depression patients remotely.

Federal DEA Rules: Can You Prescribe Controlled Substances via Telehealth Right Now?

The Short Answer: Yes, Through December 31, 2026

The DEA and HHS announced a fourth temporary extension of COVID-era telehealth flexibilities on January 2, 2026. This means you can continue prescribing Schedule II–V controlled substances via telemedicine without requiring an initial in-person exam through the end of 2026.

This applies to:

• Stimulants (Adderall, Ritalin, Vyvanse) for ADHD or treatment-resistant depression augmentation
• Benzodiazepines (Xanax, Ativan, Klonopin) for anxiety comorbid with depression
• Sleep medications (Ambien, Lunesta) for insomnia
• Buprenorphine for opioid use disorder (with specific 6-month telehealth allowance)

Non-controlled antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, etc.) were never restricted by DEA rules and can be prescribed via telehealth indefinitely, as long as you meet standard of care.

What Was the Ryan Haight Act, and Why Does It Matter?

Before COVID, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 required practitioners to conduct at least one in-person medical evaluation before prescribing any controlled substance via telemedicine. This was codified in 21 U.S.C. §829(e).

During the COVID-19 Public Health Emergency (PHE), the HHS Secretary’s declaration triggered an exception that allowed telehealth prescribing without the in-person visit. When the PHE ended in May 2023, the DEA used its regulatory authority to temporarily extend these flexibilities — first through 2023, then 2024, then 2025, and now through December 31, 2026.

What this means for you: As long as you’re practicing during this extension period, the in-person exam requirement is suspended. You can initiate controlled substance treatment for a new patient you’ve never met in person, as long as you conduct a proper evaluation via live audio-video telehealth and meet all other standard prescribing requirements (checking your state’s prescription drug monitoring program, documenting medical necessity, etc.).

What’s Changing in 2026-2027? The DEA’s Permanent Rulemaking

The DEA can’t extend temporary rules forever. On January 16, 2025, the DEA announced proposed permanent regulations for telehealth prescribing of controlled substances. Key provisions include:

Special Registration for Telemedicine:

• Providers who want to prescribe Schedule III–V controlled substances via telehealth can apply for a new ‘Special Registration for Telemedicine’
• For Schedule II controlled substances (stimulants, some pain meds), the DEA proposes an ‘Advanced Telemedicine Prescribing’ registration available only to certain specialists — specifically board-certified psychiatrists, hospice/palliative care physicians, nursing home physicians, and certain pediatric specialists
• This means psychiatrists would be explicitly permitted to prescribe Schedule II medications for psychiatric conditions (like Adderall for ADHD, Vyvanse for binge eating disorder, etc.) via telehealth without ever seeing the patient in person, once they obtain this special registration

Platform Registration:

• Telehealth companies/platforms that facilitate controlled substance prescribing would need to register with the DEA directly — this is aimed at preventing ‘pill mill’ operations that emerged during the pandemic
• For individual providers, this likely means platforms like Klarity Health would need to meet DEA registration and reporting standards, but it shouldn’t affect your ability to prescribe

What About PMHNPs?The DEA’s proposed rule specifically lists psychiatrists (MD/DO) for the Schedule II ‘advanced’ registration. It’s unclear whether PMHNPs would qualify for this category or would be limited to Schedule III–V prescribing via telehealth. This is one reason PMHNPs should watch the final rules closely — your ability to tele-prescribe stimulants after 2026 may depend on whether the DEA includes nurse practitioners in the final regulation or whether your state scope of practice provides another pathway.

Timeline: These are proposed rules. The DEA is soliciting public comments and will finalize regulations sometime in 2026. The temporary extension runs through December 31, 2026, presumably giving the DEA time to implement the permanent system before the flexibilities expire.

Bottom Line for Depression Prescribers

Right now (2026): You can prescribe virtually any medication for depression via telehealth, including controlled substances, as long as you:

• Conduct a live audio-video evaluation (not just a phone call in most states — more on this below)
• Establish a valid practitioner-patient relationship
• Document your evaluation and treatment plan
• Check your state’s prescription drug monitoring program (PDMP) before prescribing controlled substances
• Follow all other standard prescribing requirements

After 2026: You’ll likely need to obtain a DEA special telemedicine registration to continue prescribing controlled substances via telehealth, but the DEA is designing this system to make permanent what we’ve been doing during COVID. For psychiatrists, this should be straightforward. For PMHNPs, stay tuned.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-Specific Telehealth Prescribing Rules: The Six Markets That Matter

Federal DEA rules set the floor, but states can and do impose additional requirements on telemedicine practice and prescribing. Here’s what you need to know for the biggest telehealth markets.

California: Progressive on NP Independence, Standard on Telehealth

Telehealth Prescribing: California has no state law requiring an in-person exam before prescribing via telehealth. The Medical Board of California holds telehealth to the same standard of care as in-person — if a proper evaluation can be conducted via video, prescribing is allowed.

Key Rules:

• Must establish a valid patient relationship via live audio-video consultation (audio-only was allowed during COVID for mental health, but video is the standard)
• No state prohibition on controlled substance prescribing via telehealth beyond federal rules
• Must check California’s prescription monitoring program (CURES) before prescribing controlled substances

NP Scope of Practice:This is where California got interesting. Assembly Bill 890 (2020) created a pathway for experienced nurse practitioners to practice without physician supervision:

• January 2023: ‘103 NPs’ — NPs with 3+ years experience could practice in certain group settings without a supervising physician
• January 2024: ‘104 NPs’ — Experienced, board-certified NPs (including PMHNPs) can practice completely independently statewide within their specialty

What this means: A PMHNP in California who meets AB 890 requirements can diagnose and treat depression, prescribe all medications (including controlled substances if they have DEA registration), and operate a solo telehealth practice without any physician oversight. This is a massive change from California’s historical physician-supervision requirement.

Licensure: California is not part of the Interstate Medical Licensure Compact (IMLC). You must obtain a full California medical license or nursing license to treat California patients via telehealth. No shortcuts.

Practical Reality: California has strong telehealth parity laws, meaning insurers must cover tele-mental health similarly to in-person. The state actively encourages telehealth to reach underserved areas (Central Valley, rural Northern California). Large health systems like Kaiser use telepsychiatry extensively. If you’re licensed in California and want to build a telehealth practice treating depression, the regulatory environment is supportive.

Texas: Modernized Telehealth, But NPs Still Need Supervision

Telehealth Prescribing: Texas had some of the most restrictive telemedicine rules in the country until Senate Bill 1107 (2017) modernized the laws. Now, a valid practitioner-patient relationship can be established via live video telehealth without requiring an initial in-person visit.

Key Rules:

• Must use audio-video technology for the initial evaluation of new patients (phone-only generally doesn’t cut it)
• Chronic pain treatment with controlled substances via telemedicine is prohibited unless the patient has been seen in-person or via video within the last 90 days and meets other stringent conditions
• For psychiatric conditions (depression, anxiety, ADHD), there’s no state prohibition on tele-prescribing controlled substances — the chronic pain rule is specifically about pain management

What this means for depression treatment: You can absolutely start a Texas patient on an SSRI, SNRI, or even a stimulant for ADHD via a video consultation. Texas’s chronic pain restrictions don’t apply to psychiatric prescribing. However, if you’re managing a patient with depression and chronic pain who’s on opioids or benzodiazepines for the pain component, you’d need to ensure you’re meeting Texas’s in-person visit requirements for the pain management aspect.

NP Scope of Practice:Texas is one of the more restrictive states for nurse practitioners:

• All APRNs (including PMHNPs) must have a written Prescriptive Authority Agreement with a Texas-licensed physician
• The supervising physician must be available for consultation and must meet with the NP at least monthly to discuss complex cases
• The physician doesn’t need to be on-site or co-sign prescriptions, but they’re ultimately responsible for oversight

What this means: If you’re a PMHNP wanting to practice telehealth in Texas, you cannot do so independently. You need a supervising psychiatrist or physician who’s licensed in Texas and willing to enter a formal collaboration agreement. This physician reviews your practice, is available for consult, and meets with you regularly per Texas Board of Nursing requirements.

Recent legislative attempts to grant NPs independence (like SB 751 in 2023) have failed, so this supervision requirement remains in place.

Licensure: Texas requires a full Texas license to treat patients in the state via telehealth (they eliminated their separate telemedicine license). Texas is part of the IMLC for physicians, which streamlines the multi-state licensing process if you’re already licensed in another compact state.

Market Reality: Texas has a severe shortage of mental health providers — 246 of 254 counties are designated mental health professional shortage areas. This creates enormous demand for telepsychiatry, but you must navigate the NP supervision rules. For psychiatrists, Texas is a huge opportunity. For PMHNPs, you’ll need to partner with a supervising physician or join a group practice that provides one.

Florida: Telehealth-Friendly with a Unique Controlled Substance Exception

Telehealth Prescribing: Florida Statute 456.47 is one of the most telehealth-friendly laws in the country. It allows out-of-state licensed providers to register to provide telehealth services to Florida patients without obtaining a full Florida license (registration must be renewed every 2 years).

The Controlled Substance Carve-Out:Here’s what makes Florida unique: Generally, Florida law prohibits prescribing Schedule II controlled substances via telehealth except for:

1. Psychiatric disorders
2. Inpatient hospital treatment
3. Hospice care
4. Nursing home residents

What this means for psychiatrists: You can prescribe Schedule II stimulants (Adderall, Ritalin, Vyvanse) via telehealth to Florida patients as long as it’s for a psychiatric disorder like ADHD, treatment-resistant depression, or binge eating disorder. This psychiatric exception was specifically designed to ensure mental health care access.

Schedule III–V controlled substances (like benzodiazepines, sleep meds, buprenorphine) can be prescribed via telehealth without restriction.

Key Requirements:

• Must verify patient identity at the start of the telehealth encounter
• Must disclose your credentials and location to the patient
• Must obtain informed consent for telehealth services
• Must check Florida’s prescription monitoring program (E-FORCSE) before prescribing controlled substances

NP Scope of Practice:Florida is tricky for PMHNPs. In 2020, Florida passed a law allowing certain nurse practitioners to practice autonomously (HB 607), but it only applies to ‘primary care’ NPs (family medicine, general pediatrics, general internal medicine).

Psychiatric NPs were explicitly excluded from autonomous practice. This means:

• PMHNPs in Florida must have a supervising physician and a signed protocol agreement
• Even if you’re an out-of-state PMHNP registering for Florida telehealth, you need a Florida-licensed supervising physician

Licensure Options:

1. Full Florida license (MD or NP)
2. Out-of-State Telehealth Registration for physicians (streamlined process)
3. Florida is an IMLC member for physicians, making full licensure easier if you qualify

Market Reality: Florida has a massive and growing population, particularly of older adults. Telehealth demand is high. The state’s openness to out-of-state providers (for MDs) makes it attractive, but the NP supervision requirement means PMHNPs need a collaborative arrangement. Psychiatrists can take advantage of the telehealth registration to treat Florida patients relatively easily.

New York: Progressive NP Independence, Strong Telehealth Support

Telehealth Prescribing: New York has no state law requiring an in-person exam before prescribing via telehealth. The state has robust telehealth parity laws and during COVID explicitly allowed audio-only telehealth for mental health services (this has been extended for certain programs).

Key Rules:

• Standard of care applies — telehealth evaluation must be sufficient for diagnosis and treatment
• Mandatory e-prescribing for all medications (with limited exceptions)
• Must check New York’s prescription monitoring program (I-STOP) before prescribing controlled substances

NP Scope of Practice:New York made a landmark change in 2022. Previously, NPs needed a written collaborative agreement with a physician. Now:

• Experienced NPs (those with 3,600+ hours of practice) can practice without a written collaborative agreement or physician supervision
• Newly licensed NPs still need a collaborative practice agreement until they meet the hour threshold
• PMHNPs with the required experience have full practice authority — they can diagnose, treat, and prescribe independently

This became permanent law in April 2022 (previously it was a temporary COVID measure).

What this means: A PMHNP in New York who’s been practicing for a couple of years can run their own telehealth practice, see patients, prescribe antidepressants and controlled substances, and operate completely independently. This is one of the most progressive NP practice environments in the country.

Licensure: New York is not part of the IMLC or APRN compact. You must obtain a full New York license (MD or NP) to treat New York patients via telehealth.

Market Reality: New York State has most of its mental health providers concentrated in New York City and urban areas, with significant shortages upstate. Telepsychiatry programs often connect NYC specialists to upstate clinics. The state government actively supports tele-mental health to improve access. For providers, New York offers a large patient base, strong insurance parity, and (for experienced NPs) the freedom to practice independently.

Pennsylvania: Telehealth Allowed, But No Formal Statute

Telehealth Prescribing: Pennsylvania is unique in that it doesn’t have a comprehensive telehealth statute. Attempts to pass telehealth legislation have failed (often getting tied up in unrelated political disputes).

However, the Pennsylvania Department of State has issued guidance making clear that licensed professionals can provide telemedicine services as long as they:

• Meet the same standard of care as in-person practice
• Are licensed in Pennsylvania
• Follow appropriate protocols for consent, documentation, and emergency situations

Key Rules:

• No state requirement for an in-person exam before tele-prescribing
• Mandatory electronic prescribing for controlled substances (with limited exceptions)
• Must check Pennsylvania’s prescription monitoring program before prescribing controlled substances

The lack of a formal law means providers operate under general medical practice standards. Document everything, obtain explicit patient consent for telehealth, and ensure your care meets the standard you’d provide in-person.

NP Scope of Practice:Pennsylvania has not granted full practice authority to nurse practitioners:

• PMHNPs must have a collaborative agreement with a physician to practice and prescribe
• The agreement must be filed with the PA Board of Nursing
• The physician doesn’t need to co-sign prescriptions or be on-site, but must be available for consultation

Legislative efforts to grant NP independence (like SB 25) have not succeeded as of 2025, so the collaborative requirement remains.

Licensure: Pennsylvania is a member of the IMLC for physicians (joined 2021), which helps out-of-state psychiatrists get licensed to practice in PA via telehealth. No special telehealth license exists.

Market Reality: Pennsylvania has large rural areas (often called ‘Pennsyltucky’) with severe psychiatrist shortages. Telehealth is essential for reaching these communities. Major health systems like Geisinger and UPMC use telepsychiatry extensively. The regulatory environment is moderate — not as progressive as New York or California, but not restrictive like some Southern states. The main challenge for PMHNPs is finding a collaborating physician; for psychiatrists, it’s straightforward.

Illinois: Full NP Practice Authority Available, Strong Telehealth Law

Telehealth Prescribing: Illinois passed a comprehensive telehealth law in 2021 (Public Act 102-0104) that requires insurance parity for telehealth and protects the right to use telemedicine. Key provisions:

• Telehealth encounters are valid for establishing a patient relationship and prescribing
• No requirement for a prior in-person visit
• Telehealth can be provided from any location (including patient home)
• Audio-only telehealth is explicitly allowed for behavioral health services in certain circumstances

Key Rules:

• Standard of care applies — if telehealth evaluation is sufficient, prescribing is allowed
• Must check Illinois’s prescription monitoring program
• Mandatory e-prescribing for controlled substances

NP Scope of Practice:Illinois is one of the best states for PMHNPs. The state established Full Practice Authority (FPA) for APRNs in 2017:

• APRNs (including PMHNPs) can apply for FPA after completing 4,000 hours of clinical practice under a collaborative agreement plus 250 hours of additional continuing education
• With FPA, an APRN can diagnose, treat, and prescribe independently — no physician oversight required
• FPA APRNs can prescribe all controlled substances (Schedules II–V), though they must have a consultation process in place for managing chronic high-dose opioids

What this means: A PMHNP with Full Practice Authority in Illinois can manage depression patients completely independently via telehealth, including prescribing stimulants for ADHD, benzodiazepines for anxiety, or any other necessary medication. They need their own Illinois controlled substance license and DEA registration.

PMHNPs without FPA still need a collaborative agreement with a physician.

Licensure: Illinois requires a full license to practice in the state (MD or APRN). Illinois is a member of the IMLC for physicians. The state also adopted the APRN Compact in 2023, though it won’t be active until more states join.

Market Reality: Illinois has most of its psychiatrists in Chicago and the suburbs, with significant shortages in rural downstate areas. The state’s telehealth parity law and support for NP independence have made Illinois a strong market for tele-mental health. Medicaid covers telehealth extensively. For providers, Illinois offers clear rules, a supportive regulatory environment, and (for experienced PMHNPs) the ability to practice autonomously.

Psychiatrist vs. PMHNP: What’s the Difference in Telehealth Scope?

Psychiatrists (MD/DO): Full Scope, No Supervision

As a psychiatrist, your scope of practice for treating depression via telehealth is essentially unrestricted:

• You can diagnose any mental health disorder
• You can prescribe any medication — Schedule II stimulants, benzodiazepines, SSRIs, SNRIs, atypical antipsychotics, mood stabilizers, etc.
• You can provide psychotherapy or medication management
• You have independent practice authority in all 50 states (no supervision required)

What you need:

• Medical license in the state where the patient is located
• DEA registration in that state (for controlled substances)
• Compliance with that state’s telemedicine and prescribing rules

Practical advantage: Psychiatrists don’t face the patchwork of supervision requirements that PMHNPs navigate. If you’re licensed in a state and the state allows telehealth prescribing (which all do to varying degrees), you can practice.

The upcoming DEA ‘Advanced Telemedicine Prescribing’ registration for Schedule II substances is specifically designed for psychiatrists, recognizing your specialty expertise.

PMHNPs: Full Clinical Capability, Variable Autonomy

As a PMHNP, you have the clinical training and certification to diagnose and treat depression, manage medications, and provide therapy. The question is whether your state allows you to do this independently or requires physician oversight.

Full Practice Authority States (for depression care):

• California (AB 890 qualified NPs, as of 2024)
• New York (experienced NPs with 3,600+ hours, as of 2022)
• Illinois (FPA-credentialed APRNs, as of 2018)

In these states, you can operate exactly like a psychiatrist from a scope perspective — independent practice, independent prescribing, full control of your patient panel.

Restricted Practice States (for depression care):

• Texas (requires Prescriptive Authority Agreement with physician)
• Florida (requires supervising physician for psychiatric NPs)
• Pennsylvania (requires collaborative agreement with physician)

In these states, you need a formal relationship with a supervising or collaborating physician. This doesn’t mean the physician co-signs every prescription or joins every telehealth call, but they must be involved in your practice to some degree (monthly meetings, chart reviews, availability for consultation, etc.).

Controlled Substance Prescribing:Even in full-practice states, PMHNPs must obtain their own DEA registration to prescribe controlled substances. Some states have additional requirements:

• Illinois FPA NPs must complete 45 hours of pharmacology CE and have a consultation process for extended Schedule II opioid prescriptions
• State nurse practice acts may have limits on initial prescribing quantities for certain controlled substances

The DEA Rule Question:The proposed DEA ‘Advanced Telemedicine Prescribing’ registration for Schedule II substances lists psychiatrists specifically, not NPs. If this language remains in the final rule, PMHNPs may be limited to Schedules III–V for telehealth prescribing after 2026, even in full-practice states — unless their state scope of practice provides another pathway. This is one to watch closely.

Bottom Line: Choose Your State Wisely

If you’re a PMHNP building a telehealth practice, state selection matters enormously. In New York, California, or Illinois (with FPA), you can practice independently. In Texas, Florida, or Pennsylvania, you’ll need a collaborative physician relationship, which adds complexity and potentially cost.

For psychiatrists, state rules are more uniform — you just need to be licensed and follow each state’s telehealth protocols.

The Economics of Patient Acquisition: Why Telehealth Platforms Beat DIY Marketing

Let’s talk about the business reality: whether you’re a psychiatrist or PMHNP, joining a telehealth practice or platform versus building your own patient base comes down to patient acquisition cost and time to revenue.

The Reality of DIY Marketing for Mental Health

If you tried to build a solo telehealth practice from scratch using DIY marketing channels, here’s what you’d face:

Google Ads:

• Mental health keywords (like ‘online psychiatrist’ or ‘depression treatment near me’) cost $15–$40+ per click
• Most clicks don’t convert to booked patients — maybe 2-5% actually schedule
• Realistic cost per booked patient: $200–$400+
• You’d need to spend $3,000–$5,000/month on ads for a meaningful patient flow, with months of testing and optimization before you dial in profitable campaigns

SEO (Search Engine Optimization):

• Takes 6–12 months of consistent content creation, technical optimization, and link building before you rank
• Requires expertise most providers don’t have (or hiring an agency at $1,500–$3,000/month)
• Even then, you’re competing with established practices, directories, and health systems
• No guaranteed results

Directory Listings (Psychology Today, Zocdoc, etc.):

• Psychology Today charges monthly subscription fees ($30–$100+/month depending on tier) and you compete with hundreds of other providers on the same search page
• Zocdoc charges per booking ($35–$100+ per appointment) plus monthly subscription fees in some markets
• Quality of leads is inconsistent — high no-show rates are common

Total Real Cost: When you factor in ad spend, agency/consultant fees, staff time to handle and qualify leads, no-show rates, months of investment before results, and failed campaigns that don’t convert, acquiring a qualified psychiatric patient through DIY channels typically costs $200–$500+ per patient.

And that’s assuming you have the marketing expertise, budget, and patience to stick with it for 6–12 months before seeing meaningful results.

The Telehealth Platform Model: Guaranteed ROI

Platforms like Klarity Health use a fundamentally different model:

Pay-Per-Appointment:

• You pay a standard listing fee per new patient lead who books with you
• No upfront marketing spend, no monthly subscription fees, no wasted ad spend on clicks that don’t convert
• You only pay when a qualified patient actually shows up on your schedule

Pre-Qualified Patient Flow:

• Patients are already matched to your specialty (depression, anxiety, ADHD, etc.) and availability
• Built-in screening means fewer inappropriate referrals or no-shows
• Both insurance and cash-pay patient streams

Built-In Infrastructure:

• No separate telehealth platform subscription to pay
• No practice management software costs
• No credentialing hassles (many platforms handle insurance credentialing)

Control Your Schedule:

• You decide when you’re available
• Scale up or down based on your capacity
• No commitment to minimum hours

The Math

Let’s say you want to see 20 new depression patients per month via telehealth.

DIY Approach:

• Marketing spend: $3,000–$5,000/month (minimum)
• Staffing/admin time to handle leads: 10–15 hours/month
• No-show rate: 15–25% of scheduled appointments
• Time to first patient: 3–6 months
• Total cost for 6 months before steady patient flow: $18,000–$30,000

Platform Approach:

• Per-patient listing fee: Let’s say $X per new patient
• 20 patients × $X = Total monthly cost
• No upfront spend, no marketing budget, no failed campaigns
• Time to first patient: As soon as you’re credentialed (often 2–4 weeks)
• Guaranteed ROI: You know exactly what you’re paying per patient, and it’s only when they book

Even if the per-patient fee is $100–150, your total monthly spend for 20 patients is $2,000–$3,000 — less than your monthly ad budget in the DIY scenario, with zero risk of wasted spend.

The Real Value Proposition

The platform model isn’t just about lower cost — it’s about removing uncertainty:

• No gambling $5,000 on Google Ads hoping something sticks
• No waiting 9 months to rank on page one for ‘depression treatment [your city]’
• No paying for directory listings where you’re buried on page 3 of search results

You get predictable patient flow at a known cost, with infrastructure included. For most providers — especially those starting out, scaling up, or who simply want to focus on clinical work instead of marketing — that’s worth paying a per-patient fee.

When Does DIY Make Sense?

If you have:

• An established practice with brand recognition
• Marketing expertise or a dedicated marketing team
• A 12–18 month timeline to build organic patient flow
• Budget to spend $5,000–$10,000/month on marketing for 6+ months before breaking even

…then DIY marketing can eventually be cost-effective. But for the vast majority of psychiatrists and PMHNPs building or scaling a telehealth practice, a platform that handles patient acquisition removes the risk entirely.

State-by-State Comparison: Telehealth Rules, NP Scope, and Key Considerations

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service